Ablation Strategies for Atrial Fibrillation

(PARADISO Trial)

TK
Overseen ByTammy Knight
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ottawa Heart Institute Research Corporation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This study looks at participants who have undergone an ablation procedure for atrial fibrillation previously, and atrial fibrillation has occurred and a second ablation procedure is needed. The study will randomize participants to either a tailored strategy for ablation or to widening the pulmonary vein isolation procedure with or without cavotricuspid isthmus ablation. The goal is to improve freedom from recurrent atrial arrhythmias at 12 months.

Who Is on the Research Team?

FD

F. Daniel Ramirez, MD

Principal Investigator

Ottawa Heart Institute Research Corporation

Are You a Good Fit for This Trial?

This trial is for people who have had a previous ablation procedure for atrial fibrillation but their irregular heartbeat has returned, and they now need a second ablation. Participants must meet standard health requirements to safely undergo another heart procedure.

Inclusion Criteria

I have paroxysmal atrial fibrillation and have had a successful pulmonary vein isolation.
Ability to provide informed consent
I am 18 years old or older.
See 1 more

Exclusion Criteria

I have ongoing atrial fibrillation.
I have a history of ongoing abnormal heart rhythms like atrial tachycardia or flutter.
I currently have a blood clot in my heart.
See 10 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares two approaches for repeat ablation: one group gets a personalized (tailored) treatment based on individual needs, while the other receives an expanded pulmonary vein isolation with or without additional targeted ablation. Participants are randomly assigned to each group.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: Tailored StrategyExperimental Treatment1 Intervention
Group II: Control StrategyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ottawa Heart Institute Research Corporation

Lead Sponsor

Trials
200
Recruited
95,800+